Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

L.A. McKeown

October 23, 2017

News Daily News

Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies

Todd Neale

October 19, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

L.A. McKeown

September 07, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

One in Four ICD Patients Need Reintervention Within 5 Years

Ashley Lyles

August 04, 2017

News Daily News

Delirium’s Dangers Following TAVR: More Evidence

Shelley Wood

July 19, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Daily News

Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short

Yael L. Maxwell

June 26, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Caitlin E. Cox

April 21, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

News Daily News

FDA Approves Next-Gen CoreValve Evolut PRO Valve

Todd Neale

March 22, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Daily News

FDA Warns of Cybersecurity Holes in Certain Cardiac Devices and Monitoring System

Yael L. Maxwell

January 09, 2017

Advertisement

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

One in Four ICD Patients Need Reintervention Within 5 Years

Delirium’s Dangers Following TAVR: More Evidence

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

FDA Approves Next-Gen CoreValve Evolut PRO Valve

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

FDA Warns of Cybersecurity Holes in Certain Cardiac Devices and Monitoring System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content